en

PRODUCT DETAIL

KARDATUXAN 15 mg filmom obalené tablety

Code 3165E
MA number 16/0049/23-S
Product Form: tbl flm 98x15 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AF Direct factor Xa inhibitors
B01AF01 Rivaroxaban
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 22.03.2023
Validity: 22.03.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_KARDATUXAN 15 mg filmom obalené tablety_02_2023.pdf  
SPC: SPC_KARDATUXAN 15 mg filmom obalené tablety_02_2023.pdf  
Safety feature Yes
Data update: 24.03.2023
eu-flag.png sk-flag.png